BLISSGVS vs VIYASH: Stock Comparison

Bliss GVS Pharma Limited vs Viyash Scientific Ltd

Live data: 2 July 2026, 4:08 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Bliss GVS Pharma Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Viyash Scientific Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bliss GVS Pharma Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLISSGVS is more favourable on 6 of 13 scored metrics and VIYASH on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,038 Cr vs ₹4,757 Cr
P/E Ratio
BLISSGVS has a lower P/E
37.17x vs 62.48x
P/B Ratio
VIYASH has a lower P/B
3.81x vs 4.03x
EPS
BLISSGVS has higher earnings per share
₹11.99 vs ₹4.06
Dividend Yield
BLISSGVS has a higher dividend yield
0.19% vs 0%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 0%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricBLISSGVSVIYASH
Live Price₹527.1₹253.45
Day Change0.68%-2.41%
Volume3.93 L9.28 L
52-Week High₹553₹298
52-Week Low₹118₹178.13
Distance from 52W High-4.68%-14.95%

Valuation

MetricBLISSGVSVIYASH
Market Cap₹4,757 Cr₹11,038 Cr
P/E Ratio37.17x62.48x
P/B Ratio4.03x3.81x
EPS₹11.99₹4.06
Book Value₹107.21₹66.6
Dividend Yield0.19%0%

Growth

MetricBLISSGVSVIYASH
Revenue Growth (TTM YoY)29.8%0%
EPS Growth (TTM YoY)124.7%0%
Qtr Sales Growth13%129%
Qtr Profit Growth108%455%

Profitability & Leverage

MetricBLISSGVSVIYASH
ROE0%11%
ROCE11.7%19%
Net Margin13.93%6.57%
Operating Margin12.82%19.1%
Debt to Equity1.77x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSVIYASH
Promoter Holding35.01% 0.35 pp0%
FII Holding8.07% 2.38 pp4.5% 1.56 pp
DII Holding9.47% 4.43 pp3.75% 4.24 pp
Public Holding47.45% 1.7 pp30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bliss GVS Pharma Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.